PharmaEngine Profit Margin

PharmaEngine (4162.TWO) currently reports a profit margin of 52.56% as of June 2026. That compares with 65.72% in the prior-year period — down 20.0% year over year. That is above the Healthcare sector average of 9.71%. Use the charts on this page to explore PharmaEngine's profit margin history and peer comparisons.

PharmaEngine's profit margin decreased from 65.72% to 52.56% — a 20.0% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

PharmaEngine's profit margin of 52.56% is higher than the Healthcare sector average of 9.71%. That is roughly 441.6% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but PharmaEngine's current 52.56% should be judged against Healthcare norms (sector average: 9.71%) and against 4162.TWO's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of 52.56%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 9.71%. From there, open related valuation or income-statement pages for PharmaEngine, and consider following 4162.TWO for alerts when major investors trade the stock.